Transcriptomics

Dataset Information

0

Targeting the Creatine Kinase Pathway in EVI1-Positive Acute Myeloid Leukemia


ABSTRACT: Purpose: Identify new targets in EVI1-Positive Acute Myeloid Leukemia Methods: Treatment with cyclocreatine of EVI1-driven AML cell lines TF-1, UT-7 and UCSD-AML1. Cyclocreatine was purchased from Sigma-Aldrich (Sigma). TF-1, UT-7 and UCSD-AML1 cells were treated in quadruplicate with either vehicle or 3 mM cyclocreatine for 24 hours. Total RNA was extracted and profiled by RNA sequencing (HiSeq, Illumina) at BioMicroCenter from Massachusetts Institute of Technology (Cambridge, MA, USA). Results: Alteration of arginine-creatine metabolism by the small-molecule cyclocreatine selectively decreased the viability, promoted cell cycle arrest and apoptosis of EVI1-positive AML cells. Conclusions: Targeting CKMT1 is a promising therapeutic strategy for the EVI1-driven AML subtype that is highly resistant to current treatment regimens.

ORGANISM(S): Homo sapiens

PROVIDER: GSE86151 | GEO | 2017/02/13

SECONDARY ACCESSION(S): PRJNA340369

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-07-13 | PXD043333 | Pride
2024-05-21 | PXD048760 | Pride
2012-01-18 | E-GEOD-35159 | biostudies-arrayexpress
2024-02-01 | GSE252745 | GEO
2024-02-01 | GSE252743 | GEO
2024-02-01 | GSE252740 | GEO
2024-02-01 | GSE252739 | GEO
2021-11-04 | PXD026374 | Pride
2022-10-11 | GSE195497 | GEO
2023-07-12 | GSE236010 | GEO